Verition Fund Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,572
| Closed | -$32.2K | – | 2493 |
|
|
2024
Q2 | $32.2K | Buy |
+1,572
| New | +$32.2K | ﹤0.01% | 2183 |
|
|
2023
Q2 | – | Sell |
-832
| Closed | -$249K | – | 1941 |
|
|
2023
Q1 | $249K | Buy |
+832
| New | +$249K | ﹤0.01% | 1501 |
|
|
2020
Q1 | – | Sell |
-1,062
| Closed | -$248K | – | 562 |
|
|
2019
Q4 | $248K | Buy |
+1,062
| New | +$248K | ﹤0.01% | 770 |
|